Last $8.14 USD
Change Today +0.1399 / 1.75%
Volume 10.6K
CORI On Other Exchanges
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

corium international inc (CORI) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/3/14 - $8.48
52 Week Low
04/3/14 - $7.67
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

corium international inc (CORI) Related Businessweek News

No Related Businessweek News Found

corium international inc (CORI) Details

Corium International, Inc., a biopharmaceutical company, focuses on the research, development, manufacture, and commercialization of specialty pharmaceutical products. Its products include Clonidine Transdermal Delivery System (TDS), a treatment for hypertension; Fentanyl TDS, a treatment for management of chronic pain, including cancer-related pain; Crest Whitestrips, a series of four products under the Advanced Vivid, Professional Effects, One Hour Express, and Flex-Fit brands for oral care. The company is also developing AG200-15, a combination hormonal contraceptive patch in Phase III clinical trials that delivers ethinyl estradiol and levonorgestrel hormones; MicroCor hPTH(1-34), a transdermal system, which has completed Phase I clinical trials for the treatment of severe osteoporosis; and Corplex Tamsulosin that has completed Phase I clinical trials for the treatment of benign prostatic hyperplasia. In addition, its products that have completed development, scale-up, and clinical activities include motion sickness patch for the prevention of nausea and vomiting associated with motion sickness; and urology patch for treatment of a urologic condition. Further, the company is developing Donepezil and Memantine transdermal patches for the treatment of Alzheimer's disease; and Ropinerole and Pramipexole therapies for the treatment of Parkinson's disease. Corium International, Inc. has collaboration agreements with The Procter & Gamble Company, Teva Pharmaceuticals USA, Inc., Par Pharmaceutical, Inc., and Agile Therapeutics, Inc. The company was incorporated in 1995 and is headquartered in Menlo Park, California.

243 Employees
Last Reported Date: 04/3/14
Founded in 1995

corium international inc (CORI) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $418.6K
Executive Chairman and Chairman of Audit Comm...
Total Annual Compensation: $62.4K
Co-Founder and Director
Total Annual Compensation: $35.3K
Chief Financial Officer
Total Annual Compensation: $342.9K
Chief Technology Officer and Vice President o...
Total Annual Compensation: $282.1K
Compensation as of Fiscal Year 2013.

corium international inc (CORI) Key Developments

Corium International, Inc.(NasdaqGM:CORI) added to NASDAQ Composite Index

Corium International, Inc. will be added to the NASDAQ Composite Index.

Corium International, Inc. Auditor Raises 'Going Concern' Doubt

Corium International, Inc. filed its DRS/A on Jan 23, 2014 for the period ending Sep 30, 2013. In this report its auditor, Deloitte & Touche LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Corium International, Inc. Presents at 12th Annual BIO Investor Forum, Oct-08-2013

Corium International, Inc. Presents at 12th Annual BIO Investor Forum, Oct-08-2013 . Venue: The Palace Hotel, 2 New Montgomery Street, San Francisco, CA 94105, United States.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CORI:US $8.14 USD +0.1399

CORI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CORI.
View Industry Companies

Industry Analysis


Industry Average

Valuation CORI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.7x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.9x

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CORIUM INTERNATIONAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at